Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone

Mostrar otras versiones (1)

AIMS: We set out to examine the differences in metabolic profiles of at risk (overweight) patients across commonly used atypical antipsychotics (Olanzapine, Risperidone, Clozapine). We hypothesized that Olanzapine and Clozapine group will have more metabolic abnormalities compared to Risperidone. BA...

Descripción completa

Detalles Bibliográficos
Autores principales: Liew, Siew Fai, Bhanu, Gupta, Lee, Jimmy, Chee, Kok Seng, Neo, Li Qi, Tang, Charmaine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771335/
http://dx.doi.org/10.1192/bjo.2021.663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771335/
http://dx.doi.org/10.1192/bjo.2021.663

Ejemplares similares